Answers are grounded in this paper and cite their sources.
Single-center trial evaluates liver shear wave elastography using mechanical index exceeding regulators, showing no injury and reduced variability.
Background Metabolic dysfunction-associated steatotic liver disease affects 1 in 3 people worldwide. Ultrasound shear wave elastography (SWE) in obese patients, the target population for testing, is hampered by beam attenuation, leading to unreliable liver fibrosis quantification. Purpose We assess the safety and efficacy of increased push mechanical index (IPMI) above Food and Drug Administration limits to improve SWE. Methods This single-center prospective trial (July 2023 - April 2024) ([TrialNumberBlinded]) enrolled healthy adults stratified by body mass index (BMI). Participants underwent conventional push pulse (mechanical index (MI) 1.4) and IPMI (MI 2.5) SWE (GE Healthcare LOGIQ E10) performed by one of 3 sonographers and serial liver function testing (LFT) before and up to 7 days after imaging. Liver injury was defined as increased serum aspartate aminotransferase (AST), alanine transaminase (ALT), or alkaline phosphatase (ALP) (noninferiority margins: AST 7.5 U/L, ALT 12 U/L, ALP 17.5 U/L). Secondary endpoints included SWE variability and measurement number. Results 22 analyzable participants (mean age 39.6 ± 16.3 years; 15 women) had normal BMI (6), overweight (6), class 1 obesity (7), and class 2 obesity (3). Conventional shear wave speed was 1.34 ± 0.21 m/s and IPMI yielded 1.36 ± 0.20 m/s (velocities ≤ 1.34 m/s indicate minimal or no fibrosis). The mean [95% CI] LFT change from baseline to day 1 was 1) AST: -0.86 [-2.34, 0.61], p = 0.24, 2) ALT: 0.32 [-1.04, 1.68], p = 0.63, 3) ALP: 1.73 [-1.02, 4.47], p = 0.21. The upper 95% CI for all biomarkers met non-inferiority criteria. Mean IPMI interquartile range (IQR) to median ratio decreased 0.019 (29.2% relative reduction) (p = 0.01) with 0.68 [IQR: 0,0.75] (p = 0.058), fewer average attempts. Conclusion IPMI SWE in healthy volunteers did not cause injury and reduced measurement variability. IPMI SWE should be developed to improve exam quality and reliability in obese patients.
No takes yet. Share an insight, caveat, or question.
Pierce et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: